|
WO2006113458A1
(en)
|
2005-04-15 |
2006-10-26 |
Bristol-Myers Squibb Company |
Heterocyclic inhibitors of protein arginine methyl transferases
|
|
GB0602178D0
(en)
|
2006-02-03 |
2006-03-15 |
Merck Sharp & Dohme |
Therapeutic treatment
|
|
CA2648652A1
(en)
|
2006-04-04 |
2007-10-11 |
Myriad Genetics, Inc. |
Compounds for diseases and disorders
|
|
US20100035756A1
(en)
|
2006-07-12 |
2010-02-11 |
Syngenta Limited |
Triazolophyridine derivatives as herbicides
|
|
EP2205085A1
(en)
|
2007-09-25 |
2010-07-14 |
Merck Sharp & Dohme Corp. |
2-aryl or heteroaryl indole derivatives
|
|
US8785489B2
(en)
|
2008-10-17 |
2014-07-22 |
Boehringer Ingelheim International Gmbh |
Heteroaryl substituted indole compounds useful as MMP-13 inhibitors
|
|
RU2012116207A
(ru)
|
2009-09-24 |
2013-10-27 |
Ф.Хоффманн-Ля Рош Аг |
Производные индола в качестве модуляторов crac
|
|
TWI617559B
(zh)
|
2010-12-22 |
2018-03-11 |
江蘇恆瑞醫藥股份有限公司 |
２－芳基咪唑并［１，２－ｂ］嗒．２－苯基咪唑并［１，２－ａ］吡啶，和２－苯基咪唑并［１，２－ａ］吡衍生物
|
|
US9193724B2
(en)
|
2011-09-22 |
2015-11-24 |
Merck Sharp & Dohme Corp. |
Triazolopyridyl compounds as aldosterone synthase inhibitors
|
|
WO2013092467A1
(en)
|
2011-12-20 |
2013-06-27 |
F. Hoffmann-La Roche Ag |
7-azaindole inhibitors of crac
|
|
US20130158066A1
(en)
|
2011-12-20 |
2013-06-20 |
Hoffmann-La Roche Inc. |
4-azaindole inhibitors of crac
|
|
WO2013156431A1
(en)
|
2012-04-17 |
2013-10-24 |
Syngenta Participations Ag |
Pesticidally active pyridyl- and pyrimidyl- substituted thiazole and thiadiazole derivatives
|
|
EP2862853B1
(en)
|
2012-06-18 |
2020-01-22 |
Sumitomo Chemical Co., Ltd |
Fused heterocyclic compound
|
|
CN105992766A
(zh)
|
2013-12-13 |
2016-10-05 |
武田药品工业株式会社 |
作为tlr抑制剂的吡咯并[3,2-c]吡啶衍生物
|
|
EP3194394B1
(en)
|
2014-09-16 |
2019-01-09 |
Syngenta Participations AG |
Pesticidally active tetracyclic derivatives with sulphur containing substituents
|
|
RU2729187C1
(ru)
|
2015-09-29 |
2020-08-05 |
Онкотерапи Сайенс, Инк. |
Бициклическое соединение и его применение для ингибирования suv39h2
|
|
US10071079B2
(en)
|
2016-06-29 |
2018-09-11 |
Bristol-Myers Squibb Company |
[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
|
|
BR112019001270A2
(pt)
|
2016-07-30 |
2019-04-30 |
Bristol-Myers Squibb Company |
compostos indol substituídos com dimetoxifenila como inibidores de tlr7, tlr8 ou tlr9
|
|
JP7028861B2
(ja)
|
2016-09-09 |
2022-03-02 |
ブリストル－マイヤーズ スクイブ カンパニー |
ピリジル置換のインドール化合物
|
|
US11370794B2
(en)
*
|
2016-11-11 |
2022-06-28 |
Dynavax Technologies Corporation |
Toll-like receptor antagonist compounds and methods of use
|
|
WO2018165112A1
(en)
*
|
2017-03-09 |
2018-09-13 |
Oncotherapy Science, Inc. |
Bicyclic compound and use thereof for inhibiting histone methyltransferase
|
|
KR102688509B1
(ko)
|
2017-08-04 |
2024-07-24 |
브리스톨-마이어스 스큅 컴퍼니 |
[1,2,4]트리아졸로[4,3-a]피리디닐 치환된 인돌 화합물
|
|
WO2019028302A1
(en)
|
2017-08-04 |
2019-02-07 |
Bristol-Myers Squibb Company |
SUBSTITUTED INDOLE COMPOUNDS USEFUL AS TLR7 / 8/9 INHIBITORS
|
|
JP7265554B2
(ja)
*
|
2017-11-14 |
2023-04-26 |
ブリストル－マイヤーズ スクイブ カンパニー |
置換インドール化合物
|
|
KR102781141B1
(ko)
|
2017-12-15 |
2025-03-13 |
브리스톨-마이어스 스큅 컴퍼니 |
치환된 인돌 에테르 화합물
|
|
EA202091484A1
(ru)
|
2017-12-18 |
2021-03-25 |
Бристол-Маерс Сквибб Компани |
4-азаиндольные соединения
|
|
JP7304352B2
(ja)
|
2017-12-19 |
2023-07-06 |
ブリストル－マイヤーズ スクイブ カンパニー |
６－アザインドール化合物
|
|
MX2020005462A
(es)
|
2017-12-19 |
2020-09-07 |
Bristol Myers Squibb Co |
Compuestos de indol sustituidos utiles como inhibidores de receptores tipo toll (tlr).
|
|
WO2019126081A1
(en)
|
2017-12-19 |
2019-06-27 |
Bristol-Myers Squibb Company |
Amide substituted indole compounds useful as tlr inhibitors
|
|
KR102730859B1
(ko)
|
2017-12-20 |
2024-11-15 |
브리스톨-마이어스 스큅 컴퍼니 |
아릴 및 헤테로아릴 치환된 인돌 화합물
|
|
EP3728218B1
(en)
|
2017-12-20 |
2021-12-01 |
Bristol-Myers Squibb Company |
Amino indole compounds useful as tlr inhibitors
|
|
SG11202005733QA
(en)
|
2017-12-20 |
2020-07-29 |
Bristol Myers Squibb Co |
Diazaindole compounds
|
|
CN114981276B
(zh)
*
|
2020-01-09 |
2024-09-27 |
住友化学株式会社 |
杂环化合物和含有其的有害节肢动物防除组合物
|